key: cord-1002575-zeiarrbr
authors: Rolta, Rajan; Salaria, Deeksha; Sharma, PremPrakash; Sharma, Bhanu; Kumar, Vikas; Rathi, Brijesh; Verma, Mansi; Sourirajan, Anuradha; Baumler, David J.; Dev, Kamal
title: Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach
date: 2021-07-15
journal: Curr Pharmacol Rep
DOI: 10.1007/s40495-021-00259-4
sha: 74c80fceae99a1eb680659df17f1470ca83fd4cc
doc_id: 1002575
cord_uid: zeiarrbr

COVID-19, the disease caused by SARS-CoV-2, has been declared as a global pandemic. Traditional medicinal plants have long history to treat viral infections. Our in silico approach suggested that unique phytocompounds such as emodin, thymol and carvacrol, and artemisinin could physically bind SARS-CoV-2 spike glycoproteins (6VXX and 6VYB), SARS-CoV-2 B.1.351 South Africa variant of Spike glycoprotein (7NXA), and even with ACE2 and prevent the SARS-CoV-2 binding to the host ACE2, TMPRSS2 and neutrapilin-1 receptors. Since Chloroquine has been looked as potential therapy against COVID-19, we also compared the binding of chloroquine and artemisinin for its interaction with spike proteins (6VXX, 6VYB) and its variant 7NXA, respectively. Molecular docking study of phytocompounds and SARS-CoV-2 spike protein was performed by using AutoDock/Vina software. Molecular dynamics (MD) simulation was performed for 50ns. Among all the phytocompounds, molecular docking studies revealed lowest binding energy of artemisinin with 6VXX and 6VYB, with E(total) −10.5 KJ mol(−1) and −10.3 KJ mol(−1) respectively. Emodin showed the best binding affinity with 6VYB with E(total) −8.8 KJ mol(−1)and SARS-CoV-2 B.1.351 variant (7NXA) with binding energy of −6.4KJ mol(−1). Emodin showed best interactions with TMPRSS 2 and ACE2 with E(total) of −7.1 and −7.3 KJ mol(−1) respectively, whereas artemisinin interacts with TMPRSS 2 and ACE2 with E(total) of −6.9 and −7.4 KJ mol(−1) respectively. All the phytocompounds were non-toxic and non-carcinogenic. MD simulation showed that artemisinin has more stable interaction with 6VYB as compared to 6VXX, and hence proposed as potential phytochemical to prevent SARS-CoV-2 interaction with ACE-2 receptor. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40495-021-00259-4.

Introduction COVID-19 caused by a member of family Coronaries (CoV) has threatened the survival of human beings on the Earth and it has been declared as global health emergency by the World Health Organization (WHO) [1••] . Coronaviruses (CoV) are known for their ability to cause illness, with severe diseases such as Middle East respiratory syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS-CoV). Though there are other coronaviruses known to infect humans (hCoVsOC43 and 229E), but they are mild pathogens responsible for common cold. In Latin, Corona means "halo" or "crown"; thus, the name represents the structure of the virus which consists of crown like projections on its surface [2] . In 1937, coronavirus was isolated from an infectious bronchitis virus in birds which was responsible to ruin the poultry stocks [3] . Coronaviruses are the type of viruses that directly affect the respiratory tract. These are associated with the common cold, pneumonia, gut, and severe acute respiratory syndrome. Coronaviruses are zoonotic, which means they are transmitted between animals and humans [4] . A new strain, novel coronavirus (nCoV) has come into knowledge since 2019 and has emerged as a threat to mankind.

The first case of Middle East respiratory syndrome (MERS-CoV) was seen in the year 2012, a businessman in Saudi Arabia who died from viral pneumonia [5] . In 2016, a report on 1998 was published by the World Health Organization (WHO) regarding the confirmed cases of MERS-CoV infection and the death rate was approximately 36% (Middle East respiratory coronavirus (MERS-CoV) [5] . The biggest outbreak with first ever confirmed case of this disease came into existence in the year 2015 in South Korea. Including the China, the confirmed cases extend to 186 with total 36 deaths [6, 7] . Cases regarding the novel coronavirus came in to existence among the population of Wuhan, China, on December 8, 2019. Pneumonia was the first symptom of infection and most of the cases were linked to a local fish and animal market. During the research, it was seen that 2019 novel coronavirus was recognized as pathogenic agent responsible for evolution of pneumonia [8] . On January 20, 2020, laboratory in Korea confirmed the first case of coronavirus. On 23 January, 2020, the government of China announced total shutdown of country and advised the people for undergoing personal isolation. In the USA, there are five variants of SARS-Cov-2. B.1.1.7: This variant was discovered for the first time in December 2020 in the USA. It was first discovered in the UK. B.1.351: This variant was discovered for the first time in the USA at the end of January 2021. It was first discovered in December 2020 in South Africa. P.1: In January 2021, this variant was discovered for the first time in the USA. B.1.427 and B.1.429: These two variants were discovered in February 2021 in California (https://www.cdc. gov/coronavirus/2019-ncov/transmission/variant.html).

SARS-CoV-2 consists of four structural proteins: spike (S), membrane (M), envelop (E), and nucleocapsid (N) proteins [9] . Among all, S protein plays an important role in viral attachment, fusion, entry, and also act as a target for development of antibodies, entry inhibitors, and vaccines [10, 11] . The S1 domains of coronaviruses contain receptor-binding domains (RBDs) that directly bind to the cellular receptors [12, 13] . In general, SARS-CoV surface exhibits two components: S1, which contains the receptor binding domain (RBD); and S2, which contains the fusion peptide. SARS-CoV gains entry into cells through interaction of the SARS-SRBD with the cell surface receptor angiotensin-converting enzyme 2 (ACE2) [14, 15] . These interactions are followed by endocytosis, and at the low pH in endosomes, SARS-S is cleaved by a cellular protease called cathepsin L, thereby exposing the S2 domain of the spike protein for membrane fusion [16, 17] . The minimal RBD of SARS-CoV S protein is located in the S1 subunit (AA 318-510) and is responsible for viral binding to host cell receptors [18, 19] . Besides the main receptor for the angiotensin-converting enzyme 2, there are several alternative receptors, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin and liver/lymph node-specific intercellular adhesion molecule-3-grabbing integrin [20] . SARS-CoVs recognizes angiotensin-converting enzyme 2 (ACE2) as its receptor, whereas MERS-CoV recognizes dipeptidyl peptidase 4 (DPP4) as its receptor [21, 22] . Two residues (AA 479 and AA 487) in RBD determine SARS progression and tropism, and their mutations may enhance animal-to-human or human-to-human transmission [13] . Some residues (AA 109, 118, 119, 158, 227, 589, and 699) in S protein are critical strategies against this deadly viral agent, especially in high-risk groups, including people of every age group [23] . According to the previous data, the ACE2 receptor expressing cell fused with SARS-S-expressing cells adds to the cell surface by pH-independent mechanism [19] . It enhances the cell stress responses and apoptosis [24] . Binding is very critical for pathogenesis and if the binding of SARS-S with ACE2 receptor is blocked, infection can be stopped. Traditional medicinal plants produce large number of compounds which are used as therapeutics to kill the pathogens [25] . In the recent years, many reports published on antimicrobial activity of the medicinal plants [25] [26] [27] . It is expected that plant extracts and phytocompounds showing the target site other than antibiotics, a very little information is available on this type of activity of medicinal plants [26, 27] . Extracts of medicinal plants have been used from ancient times and these plants are known for their antiviral properties and less side effects. Traditionally, thyme was acclimated to treat asthma and loosen congestion in the throat and stomach [28] . The pharmacological manuscript of Chailander medical codex (fifteenth and sixteenth centuries) mentions the utilizations of wild thyme for the treatment of headaches caused by cold and laryngitis [29] . During the Renaissance period (sixteenth and seventeenth centuries), wild thyme was utilized internally to treat malaria and epilepsy [30] . Traditionally in many countries, areal part of T. serpyllum is utilized as anthelmintic, a vigorous antiseptic, an antispasmodic, a carminative, deodorant, diaphoretic, disinfectant, expectorant, sedative, and tonic. Thymus serpyllum additionally used to treat respiratory quandaries [29] . In western Balkans, thymus species used to amend b l o o d c i r c u l a t i o n a n d a s a n t i c h o l e s t e r o l e m i c , immunostimulant [31] . Carvacrol and thymol are isomers, belonging to the group of monoterpenic phenols with potent antiseptic properties. Chauhan et al. [32] reported thymol (25-200 mg kg −1 ) as immunomodulatory in cyclosporine Atreated Swiss albino mice by enhancing the expression of cluster of differentiation 4 (CD4), cluster of differentiation 8 (CD8), and Th1 cytokines via upregulation of IFN-4 expression and enhanced secretion of interleukin-12 (IL-12). Antiviral property of Thymus serpyllum [33] and thymol is already reported [34] . Pilau et al. [35] reported the antiviral activity of carvacrol from Lippia graveolens against human and animal virus (herpes simplex virus, acyclovir-resistant herpes simplex virus 1, bovine herpesvirus 2, respiratory syncytial virus; human rotavirus, bovine viral diarrhea virus). Antiviral nature of Emodin was also reported in several studies [36, 37] . Study from Efferth et al. [38] showed in vitro antiviral properties of artemisinin against hepatitis B virus, hepatitis C virus, and bovine viral diarrhea. Keeping in view the antiviral potential of Himalayan herbs, the current study was focused on the identification of potent phytocompounds from Himalayan herbs (Rheum emodi, Thymus serpyllum, and Artemisia annua) to cure a dangerous COVID-19.

Bioinformatics Tools Open Babel GUI [39] , UCSF Chimera 1.8.1 [40] , Pubchem (www.pubchem.com), RCSB PDB (http://www.rscb.org/pdb), PDBsum (www.ebi.ac.uk/ pdbsum), and Autodock/vina software [41, 42] were used in the present investigation.

Four major phytocompounds of three medicinal plants-emodin of Rheum emodi, thymol and carvacrol of Thymus serpyllum, and artemisinin of Artemisia annua-were used for the docking studies. The 3-dimensional structures of all the phytocompounds and chloroquine were obtained from PubChem (www.pubchem.com) in .sdf format. The .sdf file of the phytocompounds was converted into PDB and pdbqt format by using the Open Babel tool [43] . Table 1 shows molecular structure, molecular weight, pharmacological properties, plant source, and percentage of phytocompounds in the respective plants and antimalarial drug chloroquine. Targets of phytocompounds and standard drug chloroquine were predicted by using SwissADME online server. 

The aim of the drug scan was to see whether selected phytochemicals met the drug-likeness criteria. Lipinski's filters using Molinspiration (http://www.molinspiration.com) were applied for examining drug-likeness attributes, including quantity of hydrogen acceptors (should not be more than 10) , quantity of hydrogen donors (should not be more than 5), molecular weight (mass should be more than 500 Daltons), and partition coefficient log P (should not be less than 5). The smiles format of each of the phytochemical was uploaded for the analysis [58] .

Absorption, distribution, metabolism, excretion, and toxicity (ADMET) screening was done to determine the absorption, toxicity, and drug-likeness properties of the selected ligands. The 3-dimensional structures of ligands such as emodin, thymol, carvacrol, artemisinin, and chloroquine were saved in .smiles format and chloroquine was uploaded on SWISSADME (Molecular Modeling Group of the SIB (Swiss Institute of Bioinformatics), Lausanne, Switzerland), admetSAR (Laboratory of Molecular Modeling and Design, Shanghai, China), and PROTOX web servers (Charite University of Medicine, Institute for Physiology, Structural Bioinformatics Group, Berlin, Germany) for ADMET screening. SWISSADME is a web tool used for the prediction of ADME and pharmacokinetic properties of a molecule. The predicted results consist of lipophilicity, water solubility, physicochemical properties, pharmacokinetics, drug likeness, medicinal chemistry, and Brain or Intestinal Estimated permeation method (blood-brain barrier and PGP ± prediction). AdmetSAR provides ADMET profiles for query molecules and can predict about fifty ADMET properties. Toxicity classes are as follows: (i) category I contains compounds with LD50 values ≤ 50 mg kg −1 , (ii) category II contains compounds with LD 50 values > 50 mg kg −1 but 500 mg kg −1 but 5000 mg kg −1 (Cheng, 2020). PROTOX is a rodent oral toxicity server predicting LD 50 value and toxicity class of query molecule. The toxicity classes are as follows: class 1: fatal if swallowed (LD50 ≤5), class 2: fatal if swallowed (55000) [59] .

The docking of selected ligands to the catalytic triad of protein was performed by using AutoDock/Vina [41] . Docking was performed to obtain populations of conformations and orientation for ligands at binding sites. Docking was performed to study the interactions between SARS-CoV-2 receptors such as 6VXX (closed state), 6VYB (open state), 7NXA (SARS-CoV-2 B.1.351 variant), 7MEQ, 6MID, and neuropilin-1 (4DEQ) with major phytocompounds of R. emodi, T. serpyllum, and A. annua and .pdb file of proteins-ligand complexes was generated. All the bonds of ligands were set to be rotatable. All calculations for protein-ligand docking were performed using the Lamarckian genetic algorithm (LGA) method. The best conformation was chosen with the lowest docked energy, after the completion of docking search. The .pdb complex of protein and ligand was analyzed by using Discovery Studio (https://discover.3ds.com/d) to study the list of interactions between protein and ligand complex. Detailed visualization and comparison of the docked sites of target proteins and ligands were done by using Chimera [60] .

In order to further verify the accuracy of docking observations, the two best complexes of S-protein were selected for extensive MD simulation for 50ns. Both the complexes were introduced into Desmond software to study the binding stability of the ligand within the binding site of S-protein [60] . Both complexes were prepared prior to simulation to remove any structural error as described earlier [61, 62] . Both the complexes were solvated in TIP3P water model and 0.15 M NaCl to mimic a physiological ionic concentration. This MD simulation was performed with OPLS3e force field.

Early preclinical production is supported by drug-likeness filters, which help to prevent expensive late-stage preclinical and clinical failure. The Lipinski rule of 5 was used to evaluate the drug-likeness properties of the emodin, thymol, carvacrol, artemisinin, and chloroquine. The emodin, thymol, carvacrol, and artemisinin followed the Lipinski's rule of five, whereas chloroquine showed one violation (Table 2) .

The comparative ADME properties predicted by SwissADME of emodin, thymol, carvacrol, artemisinin, and chloroquine are summarized in Table 3 . Consensus Log Po/w value of ˂5 indicates good aqueous solubility, which means that an adequate amount of drug can reach and be maintained inside the body through oral administration. The emodin, thymol, carvacrol, artemisinin, and chloroquine showed consensus Log Po/w value of < 5 (Table 3) . TPSA indicates permeability of compounds into the cells. A TPSA value of < 140 Å2 is required for good permeation of compound into the cell membrane and value < 90 Å2 is required to permeate through blood-brain barrier. All the selected phytocompounds showed TPSA value < 90 Å2, except 94.83 Å2 for emodin, indicating good permeability of selected phytocompounds into the cell as well as through blood-brain barrier. Lipinski's rule of five helps to determine drug likeness of the compound and orally active drug should not violate the Lipinski's rule. The emodin, thymol, carvacrol, artemisinin, and chloroquine followed Lipinski's rule of five ( Table 3 ). The predicted cellular targets of emodin, thymol, carvacrol, artemisinin, and chloroquine are shown in Table 4 . Toxicity of emodin, thymol, carvacrol, artemisinin, and chloroquine was predicted by PROTOX-II and admetSAR and results are summarized in Table 5 . It was observed that emodin, thymol, carvacrol, artemisinin, and chloroquine are non-carcinogenic and non-cytotoxic in nature and are safe to administer. However, LD 50 value of emodin (5000 mg kg −1 ) and artemisinin (4228 mg kg −1 ) calculated from Protox II was higher than that of all other phytocompounds and chloroquine. This suggests that natural phytocompounds are safer even at higher dosage than that of chemically synthesized chloroquine. (Table 6 and Fig. 2 and S2) . Artemisinin in complex with 6VYB makes week hydrogen bonds with SER 730 and THR 778 and showed hydrophobic interactions with TRP 104, ILE 119, ILE 126, VAL 128, PHE 194, and VAL 227 (Table 5 and Fig. 2 and Figure S2 ).

In (Table 6 and Fig. S4 ). Neuropilin-1 interacts with emodin (−6.6 kcal mol −1 ), carvacrol and artemisinin (−5.8 kcal mol −1 ), thymol (−5.6 kcal mol −1 ), and chloroquine (4.9 kcal mol −1 ). Emodin makes hydrogen bond (moderate strength) with ILE 147 and hydrophobic interactions with TYR 24, TRP 28, THR 43, ASP 47, THR 76, LYS 78, TYR 80, and GLY 141 ( Table 6 and Fig. S5) . Similarly, Angiotensin-converting enzyme-2, ACE2 showed best interaction with artemisinin (−7.4 kcal mol −1 ), followed by emodin (−7.3 kcal mol −1 ), thymol (−6.9 kcal mol −1 ), chloroquine (−6.5 kcal mol −1 ), and carvacrol (−6.1 kcal mol −1 ). Artemisinin do not make any hydrogen bonds with ACE2, but showed hydrophobic interactions with LEU 545, ALA 273, LEU 495, SER 487, LEU 269, SER 491, ILE 492, ASP 270, TYR 488, VAL 552, PHE 549, and GLU 553 (Table 6 and Figure S6 ).

The nature of hydrogen bonds was determined on the basis of donor-acceptor distances in protein secondary structure elements. Jeffrey and Jeffrey [63••] categorize hydrogen bonds with donor-acceptor distances of 2.2-2.5 Å as "strong," 2.5-3.2 Å as "moderate" (mostly electrostatic), and 3.2-4.0 Å as "weak, electrostatic." Hydrogen bond interaction and hydrophobic interactions of these phytocompounds with target proteins were analyzed through discovery studio and results are summarized in Table 6 . 

Among all the selected phytocompounds, artemisinin showed the best binding affinity with both the spike proteins of SARS-CoV-2 (6VXX closed conformation, 6VYB open confirmation) and these complexes were selected for MD simulation [60, 64, 65] . The binding and conformational stability of the artemisinin complex with the spike receptor protein is a major factor to advocate the inhibitory action of the artemisinin against SARS-CoV-2 infection. MD simulations were carried out for 50ns at 300 Kelvin temperature and 1.01325 bar pressure. Both the complexes of artemisinin with spike receptors (PDB ID: 6VXX, and 6VYB) have 6Na + ions to neutralize complexes. The artemisinin complexes with 6VXX and 6VYB have water molecules 58601 and 72196, respectively. The Na + and Cl − ions were added in the environment to these complexes, such that artemisinin +6VXX (Cl − 50.573 nM; Na + 52.435 nM) and artemisinin+6VYB (Cl − 50.620 nM; Na + 50.620 nM) could mimic physiological ionic concentration.

The Ramachandran mapping of S-protein residues after analyzing the stereochemical geometry of artemisinin+6VXX, and artemisinin+6VYB after MD simulation revealed a very acceptable number of residues in favored region ( Fig. 3 ; Table  7 ). These complexes possess outlier residues within the acceptable range (less than 1.0%). Overall, spike protein in complex with artemisinin showed a sterically acceptable conformation of molecule after MD simulation, indicating the stability of the complexes.

The root mean square deviation (RMSD) of the Cα of the Sprotein molecule was analyzed for 50-ns simulation for 6VXX and 6VYB complexed with artemisinin. The Cα RMSD plot for 6VXX (Fig. 4A ) gets stabilized at 35ns and remains stabled for the entire simulation period. Ligand RMSD was 4Å at 30ns and then changed to 10Å at 40ns, which is further changed to 14Å at 50-ns time line (Fig. S7) . The ligand RMSF plot for artemisinin fit over 6VXX protein showed ligand fluctuation with respect to protein. The high RMSF of atom 7 and 16-18 is mainly due to the exposure to solvent (Fig. 4B) . The trajectory analysis reveals conformational shift in artemisinin within binding pocket, which indicates artemisinin is less stable in the binding pocket of 6VXX (closed conformation) complex. It has been proposed that 6VYB (open conformation) is more significant for drug Transient receptor potential cation channel subfamily A member 1, Cyclooxygenase-1, GABA-A receptor; alpha-1/beta-2/gamma-2, Serotonin 2b (5-HT2b) receptor, GABA-A receptor; alpha-1/beta-3/gamma-2 Carvacrol

Cyclooxygenase-1, Transient receptor potential cation channel subfamily A member 1, Serotonin 2b (5-HT2b) receptor, Carbonic anhydrase II, GABA-A receptor; alpha-1/beta-3/gamma-2, Chloroquine

Voltage-gated calcium channel alpha2/delta subunit 1, Serotonin 1a (5-HT1a) receptor, Histamine H3 receptor, Histamine N-methyltransferase, Alpha-1d adrenergic receptor designing. The RMSD plot for 6VYB (Fig. 5C ) clearly showed stable interaction between artemisinin and binding pocket residues of 6VYB (open conformation) during the simulation period. Artemisinin showed less fluctuation in open state protein than the closed state protein (Fig. 4C, D) . Furthermore, 6VYBor 6VXXcomplex with artemisinin showed hydrophobic interaction (Trp104, Ile119, Val126, Ile128, Tyr170, Phe192, Phe194, Ile203, Leu226, and Leu229), H-bond interaction (Asn121, Arg192, Ser 205), and water bridges (Asn121, Thr124, Arg192, Ser205, His207) (Fig. 5A, B) . There was no salt bridge interaction developed between the 6VYB or 6VXX complex with artemisinin. The observed binding free energy for artimisnin+6VYB complex was −74.54 kcal mol −1 , while observed binding free energy for artimisnin+6VXX complex was −55.5 kcal mol −1 . The above results clearly advocate the stability of artemisinin in open state protein instead of closed state protein.

From the beginning of twenty-first century, three coronaviruses, viz. severe acute respiratory syndrome coronavirus (SARS-CoV) [4] , Middle East respiratory syndrome coronavirus (MERS-CoV) [5] , and SARS-CoV-2 have crossed the species barrier and resulted in deadly pneumonia in humans [66, 67] . SARS-CoV-2 has caused death of approximately 3.3 million people all around the world. The treatment is symptomatic and oxygen therapy represents the major hydrogen bonds, hydrophobic, and water bridges interactions are as indicated. X-axis showed amino acid residues and y-axis indicated interaction fraction 6M71). Selailia and Chemat [73••] reported hydroxyl chloroquine and artemisinin interact in the same binding pocket of SARS-CoV-2 protein (6LZG); artesunate, artemisinin, and artenimol showed two mode of interaction with LYS 353 and LYS 31; and they also reported the extraction protocol of artemisinin from Artemisia annua. Walls et al. [52] suggested that S-protein is highly pathogenic in human coronaviruses and appears to exist in partially opened states, while S-protein remains largely closed in human coronaviruses that are responsible for common colds. It was also proposed that the S-protein of pathogenic coronaviruses exists in open and close conformation. The current in silico study provides evidence that ligand binding affinity is different for open and closed conformation of S protein and artemisinin interacts more stably with the open conformation of spike protein, than the closed conformation, thus can be used as a potent drug to cure COVID-19. Basu et al. [74••] studied the molecular docking of five phytocompounds (hesperidin, anthraquinone, thein, chrysin, and emodin) with spike protein of SARS-CoV2 and ACE2 receptor. It was shown that hesperidin can bind with ACE2 protein and bound structure of ACE2 protein and spike protein of SARS-CoV2 noncompetitively. The study proposed that the presence of hesperidin, the bound structure of ACE2, and spike protein fragment become unstable. Srivasta et al. [75••] reported the interactions of antimalarial compounds (Mepacrine, Chloroquine, Quinin, Hydroxychloroquine, Artemisinin, Phomarin, and Proguanil) with main protease (PDB ID 6LU7) of SARS-CoV2. They found that mepacrine showed best interactions with 6LU7 (−8.89 kcal mol −1 ) followed by chloroquine (−8.15 kcal mol −1 ), quinin (−7.77 kcal mol −1 ), hydroxychloroquine (−7.62 kcal mol −1 ), artemisinin (−7.34 kcal mol −1 ), phomarin (−7.13 kcal mol −1 ), and proguanil (−6.69 kcal mol −1 ). Previous studies reported the binding affinity of emodin, artemisinin, and chloroquine against RNA binding domain of nucleocapsid phosphoprotein and main protease of SARS-CoV-2. The current study provides evidence that ligand binding affinity is different for open and closed conformation of S protein. This study also provides the evidence that phytocompounds can inhibit spike protein variant of SARS-CoV-2. Artemisinin interacts more stably with the open conformation of spike protein, than the closed conformation and emodin binds strongly with variant of spike protein SARS-CoV-2; thus, artemisinin and emodin need further attention through in vitro and in vivo studies to be tested to inactivate the SARS-CoV-2.

In this study, we are proposing the artemisinin as a lead phytocompound to inactivate the SARS-CoV-2 virus through inhibiting S-protein, especially in open state conformation.

The MD simulation for 50ns showed both the S-protein complexes were stable as there are less than 1.0% outlier amino acid residues in Ramachandran plot developed after MD. The RMSD plot for both complexes and ligand RMSF has shown the stability of artemisinin within the binding pocket of Sprotein. The present study proposed a safe and less toxic artemisinin for the treatment for SARS-CoV-2 infection, which can be further validated through in vitro and in vivo studies.

Supplementary Information The online version contains supplementary material available at https://doi.org/10.1007/s40495-021-00259-4.

particular interest, published recently, have been highlighted as: •• Of major importance

Agha R World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)

Studies on coronaviruses causing enteric infections in domestic animals in Japan. Graduate School of Veterinary Medicine and Life Science Nippon Veterinary and Life Science University

Serological studies of avian infectious bronchitis virus

A novel coronavirus associated with severe acute respiratory syndrome

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities

Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea

Antiviral activity and molecular docking of active constituents from the root of Aconitum carmichaelii

Prospects for a MERS-CoV spike vaccine

The spike protein of SARS-CoV-a target for vaccine and therapeutic development

MERS-CoV spike protein: targets for vaccines and therapeutics

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

Coronaviruses post-SARS: update on replication and pathogenesis

The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex

pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN

The secret life of ACE2 as a receptor for the SARS virus

The SARS-CoV S glycoprotein: expression and functional characterization

Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

Manipal: College of Pharmaceutical Sciences

Reversal of efflux mediated tetracycline resistance in Staphylococcus aureus clinical isolates by Ginseng prosaponenins

Screening and isolation of antibiotic resistance inhibitors from herb materials -resistance inhibition of volatile components of Korean aromatic herbs

Ancient herbs: Getty Publications

Review of ethnobotanical, phytochemical, and pharmacological study of Thymus serpyllum L. Evid. Based Complementary Altern

Epilepsy in the renaissance: a survey of remedies from 16th and 17th century German herbals

A cross-cultural comparison of folk plant uses among Albanians, Bosniaks, Gorani and Turks living in south Kosovo

Stimulatory effects of Cuminum cyminum and flavonoid glycoside on Cyclosporine-A and restraint stress induced immune-suppression in Swiss albino mice

Antiviral substances in plants of the mint family (Labiatae). III. Peppermint (Menthapiperita) and other mint plants

Volatile constituents of three Thymus species grown wild in Iran

Antiviral activity of the Lippia graveolens (Mexican oregano) essential oil and its main compound carvacrol against human and animal viruses

Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures

Emodin inhibition of influenza A virus replication and influenza viral pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB pathways

The antiviral activities of artemisinin and artesunate

Open Babel: An open chemical toolbox

UCSF Chimera-a visualization system for exploratory research and analysis

AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

In silico and In vitro evaluation of the anti-inflammatory and antioxidant potential of Cymbopogon citratus from North-western Himalayas

MER3 is required for normal meiotic crossover formation, but not for presynaptic alignment in rice

Bioassay guided fractionation of rhizome extract of Rheum emodi wall as bio-availability enhancer of antibiotics against bacterial and fungal pathogens

Quantification of artemisinin in Artemisia annua extracts by 1H-NMR

Validation of a high-performance liquid chromatography technique for the investigation of thymol and carvacrol in Thymus serpyllum l. indigenous to balochistan

Emodin inhibits current through SARS-associated coronavirus 3a protein

Emodin is identified as the active component of ether extracts from Rhizoma Polygoni Cuspidati, for anti-MRSA activity

The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine

Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils

This reference is relevant to SRAS-COV-2 and published recently

Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein

Antibody evasion by the P. 1 strain of SARS-CoV-2

Crystal structure of human TMPRSS2 in complex with Nafamostat: Proten data bank

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus

In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs

Overview on the Rule of Five

ProTox-II: a webserver for the prediction of toxicity of chemicals

Discovery of new hydroxyethylamine analogs against 3CLpro protein target of SARS-CoV-2: Molecular docking, molecular dynamics simulation and structure-activity relationship studies

An introduction to hydrogen bonding

In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: a drug repurposing approach

Schrödinger Release 2020-2: Prime

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A novel coronavirus from patients with pneumonia in China

Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction

Destabilizing the structural integrity of COVID-19 by caulerpin and its derivatives along with some antiviral drugs: an in-silico approaches for a combination therapy

In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly

Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat

Comparative docking studies on curcumin with COVID-19 proteins

Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19

Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2

silico investigations on the potential inhibitors for COVID-19 protease

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Ethics Approval and Consent to Participate Not applicable.

Conflict of Interest The authors declare that they have no competing interests.Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.